An International Journal Clinical Rhinology

Register      Login

VOLUME 5 , ISSUE 1 ( January-April, 2012 ) > List of Articles

Radiology Quiz

Radiology Quiz

Citation Information : Radiology Quiz. Clin Rhinol An Int J 2012; 5 (1):53-53.

DOI: 10.5005/jp-journals-10013-1121

License: CC BY-ND 3.0

Published Online: 00-04-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Hughes GB, Sharpino G, Hunt W, Tucker HM. Management of the congenital midline nasal mass: A review. Head Neck Surg 1980;2:222-33.
  2. Bradley PJ, Singh SP. Congenital nasal masses diagnosis and management. Clin Otolaryngol 1982;7:87-97.
  3. Karma P, Rasanen O, Karja J. Nasal gliomas: A review and report of two cases, Laryngoscope 1977;87;1169-79.
  4. Mirra SS, Pearl GS, Hoffman JC, et al. Nasal glioma with prominent neuronal component. Arch Pathol Lab Med 1981; 105:540-41.
  5. Patterson K, Kapur S, Chandra RS. Nasal gliomas and related brain heterotopias: A pathologist's perspective. Pediatr Pathol 1986;5:353-62.
  6. Chau HN, Hopkins C, McGilligan A. A rare case of nasal glioma in the sphenoid sinus of an adult presenting with meningoencephalitis. Eur Arch Otorhinolaryngol 2005;262: 592-94.
  7. Rahbar R, Resto VA, Robson CD, et al. Nasal glioma and encephalocele: Diagnosis and management. Laryngoscope 2003; 113:2069-77.
  8. Seibert RW, Seibert JJ, Jimanez JF, et al. Nasopharyngeal brain heterotopia: A cause of upper airway obstruction in infancy. Laryngoscope 1984;94:818-19.
  9. Bradley PJ, Singh SD. Nasal glioma. J Laryngol Otol 1985;99: 247-52.
  10. Yokoyama M, Inouye N, Mizuno F. Endoscopic management of nasal glioma in infancy. Int J Pediatr Otorhinolaryngol 1999; 51:51-54.
  11. Burckhardt W, Tobon D. Endoscopic approach to nasal glioma. Otolaryngol Head Neck Surg 1999;120:747-48.
  12. Lowe RS, Robinson DW, Ketchum LD, et al. Nasal gliomata. Plas Reconstr Surg 1971;47:1-5.
  13. Barkovich AJ, Vandermarck P, Edwards MS, Cogen PH. Congenital nasal masses: CT and MR imaging features in 16 cases. Am J Neuroradiol 1991;12;105-16.
  14. Dupin CL, LeJeune FE Jr. Nasal masses in infants and children. South Med J 1978;71:124-28.
  15. Thomson HG, Al-Qattan MM, Becker LE. Nasal glioma: Is dermis involvement significant? Ann Plast Surg 1995;34:168-72.
  16. Whitaker SR, Sprinkle PM, Chou SM. Nasal glioma. Arch Otolaryngol 1981;107:550-54.
  17. Agýrdýr BV, Derin AT, Ozbilim G, Ozcaglar HU. Endoscopic management of the intranasal glioma. Turkey Journal of Pediatric Surgery 2004;39(10):1571-73.
  18. Wu CL, Tsao LY, Yang AD, Chen MK. Endoscopic surgery for nasal glioma mimicking encephalocele in infancy. Skull Base 2008;18(6):401-04.
  19. Zinreich SJ, Kennedy DW, Rosenbaum AE. Paranasal sinuses: CT imaging requirements for endoscopic surgery. Radiology 1987;163:769-75.
  20. Stoney P, Probst L, Shanker L. CT scanning for functional endoscopic sinus surgery: Analysis of 200 cases with reporting scheme. J Otolaryngol 1993;22:72-78.
  21. Elahi M, Frenkiel S, Remy H, Just N, Haddad M. Development of a standardized proforma for reporting computerized tomography images of paranasal sinuses. J Otolaryngol 1996; 25:113-20.
  22. Ilium P. Septoplasty and compensatory inferior turbinate hypertrophy: Long term results after randomized turbinoplasty. Eur Arch Otorhinolaryngol 1997;1:89-92.
  23. Ginzel A, Ilium P. Nasal mucociliary clearance in patients with septal deviation. Rhinology 1980;18:177-81.
  24. Suzuki H, Yamaguchi T, Furukawa M. Rhinologic computed tomographic evaluation in patients with cleft lip and palate. Arch Otolaryngol Head Neck Surg 1999;125:1000-04.
  25. Jin HR, Lee JY, Jung WJ. New description method and classification system for septal deviation. J Rhinol May 2007;14(1):27-31.
  26. Yousem DM, Kennedy DW, Rosenberg S. Ostiomeatal complex risk factors for sinusitis: CT evaluation. J Otolaryngol 1991; 20:419-24.
  27. Calhoun KH, Waggenspack GA, Simpson CB. CT evaluation of the paranasal sinuses in symptomatic and asymptomatic populations. Otolaryngol Head Neck Surg 1991;104:480-83.
  28. Tao Z, Zhang J, Yang Q, Xiao B, Kong Y. Differences of anatomic variations in ostiomeatal complex between two sides of the deviated septum. Zhonghua Er Bi Yan Hou Ke Za Zhi 2001;36(2):132-34.
  29. 2011 European association of the study of the liver hepatitis C virus clinical practice guidelines. Liver Int 2012;32 (Suppl) 1:2-8
  30. APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatol Int 2012;6:409-35
  31. An evaluation of the potential cost-effectiveness of noninvasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol 2009;24:786-91
  32. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. Hepatol Res 2010;40: 383-92
  33. Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology 2010;51:1945-53
  34. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2009;24:1002-07
  35. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther 2011; 16:165-72
  36. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008;27:1261-68
  37. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290-97
  38. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and noninvasive scores. J Hepatol 2009;50:59-68
  39. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006;45:230-35
  40. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009;49:1954-61. Transient Elastography (Fibroscan®): A New Look of Liver Fibrosis and Beyond Euroasian Journal of Hepato-Gastroenterology, January-June 2013;3(1):70-77 77 EJOHG 42. Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, Park JY, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011;53:885-94
  41. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970-79, 1979 e1-3
  42. Liver stiffness measurement by transient elastography as a predictor on post-hepatectomy outcomes. Ann Surg 2012 Sep 21
  43. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®). Ann Surg Oncol 2012 Dec;19(13):4278-86
  44. Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360-69
  45. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 2008;6:1027-35
  46. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380-84
  47. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008;47:592-95
  48. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008; 48:1718-23
  49. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010;52:206-10
  50. Hepatic amyloidosis increases liver stiffness measured by transient elastography. Acta Gastroenterol Belg 2010;73:52-54
  51. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009;29:1500-06
  52. Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology 2010;51:828-35
  53. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 2011;26:300-05
  54. Normal liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country. Hepatology 2012;55:584-93
  55. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005;100:616-23
  56. Noninvasive measures of liver fibrosis. Hepatology 2006;43:S113-20
  57. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-92
  58. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr 2012;171:1417
  59. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 2010; 30:1043-48
  60. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®. J Hepatol 2012;56:833-39
  61. Transient elastography with a new probe for obese patients for noninvasive staging of nonalcoholic steatohepatitis. Eur Radiol 2010;20:2390-96
  62. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;55:199-208
  63. National, regional and global trends in bodymass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377:557-67
  64. Prevalence of nonalcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: A population study using protonmagnetic resonance spectroscopy and transient elastography. Gut 2012;61:409-15
  65. Novel controlled attenuation parameter for noninvasive assessment of steatosis using FibroScan®: Validation in chronic hepatitis C. J Viral Hepat 2012;19:244-53.
  66. Splenic cysts and tumors: Diagnosis and management. J Chir (Paris) 2005;142:6-13
  67. Cystic lymphangioma of the spleen mimicking hydatid disease. J Clin Gastroenterol 1998;26:309-11
  68. Lymphangiomatosis masquerading as metastatic melanoma. Am Surg 2006;72:367-70
  69. Partial splenectomy for benign cystic lesions of the spleen. J Pediatr Surg 1986;21:749-52
  70. Laparoscopic splenectomy. Arch Surg 1999;134:99-103
  71. Laparoscopic splenectomy for hematological disorders. Our experience in adult and pediatric patients. Int Surg 1998;83:303-07
  72. Laparoscopic splenectomy: Evolution and current status. Surg Laparosc Endosc 1998;9:1-8
  73. Hematologic diseases laparoscopic splenectomy. Rev Méd Chile 2004;132:189-94
  74. Laparoscopic treatment of to benign splenic cyst. Surg Endosc 1997;11:766-68
  75. Videolaparoscopic approach of the splenic cyst: A case report. J Soc Laparoendosc Surg 2000;4:23-26
  76. Laparoscopic treatment of splenic cysts. J Soc Laparoendosc Surg 2001;5:313-36
  77. Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg 2008;32:2444-49
  78. Intraabdominal cystic lymphangioma in childhood. Report of 2 cases. Zentralbl Chir 1999;124:159-62
  79. CT findings in primary vascular tumors of the spleen. AJR 1996;166:1097-101.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.